Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04939519 · ClinicalTrials.gov registry record · NA
SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Vaccination Rates Among Utah Community Health Centers
A NA study, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 65,300
- Enrollment target
NCT04939519: Completed NA study, sponsored by University of Utah.
NCT04939519 is a NA study that has completed, run by University of Utah. The registered enrollment target is 65,300 participants, above the 1,402-participant average among 58,714 other NA trials with a reported enrollment target (4558% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04939519, a NA study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 65,300 participants
- Enrollment target
Study Summary
SCALE-UP Utah is a community-academic partnership to address COVID-19 among Utah community health centers. The long-term objective of the project is to increase the reach, acceptance, and uptake of COVID-19 vaccines among Utah's Community Health Center patient population. The study will compare two practical, feasible, scalable interventions to increase COVID-19 vaccine uptake in Utah Community Health Centers: 1. Text Messaging (TM): population health management (PHM) intervention that analyzes EHR data to automatically identify patients eligible for COVID-19 vaccination and uses bi-directional text messaging to help connect patients to a vaccination site; 2. Patient Navigation (PN): PHM intervention to increase vaccination uptake among eligible patients (identified via TM) using patient navigation (e.g., motivating patients, addressing logistics and barriers). The project will employ a rapid cycle research approach in which interventions are tested on a small scale, using short time frames (e.g., \<1 month) and cyclical evaluation cycles.This process involves implementing intervention messages with a small number of clinics or patients, evaluating the outcomes, and either adapting the intervention messages based on findings (and retesting) or disseminating effective approaches to additional clinics or patients. A critical feature of these cycles is the ability to quickly test and refine messages in a limited setting before broader implementation. Throughout the study, intervention messages were updated or adapted in response to evolving public health guidelines, testing procedures, and policy recommendations (e.g., priority populations by age group or geographic area, as advised by the Utah Department of Health and Human Services and relevant federal agencies). However, these updates did not alter the fundamental structure of the intervention arms. Participants were randomized to one of two main conditions-Text Messaging (TM) or Text Messaging plus Patient Naviga
Primary Outcome
Proportion of patients who receive a COVID-19 vaccine out of the total patient population
Interventions
- BEHAVIORAL Patient Navigation (PN)
- BEHAVIORAL Text-Messaging (TM)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65,300 participants |
| Start Date | 2021-03-29 |
| Est. Completion | 2023-02-28 |
| Phase | NA |
What the finished NCT04939519 record still lists
NCT04939519 is an interventional study that assigns participants to a tested intervention. Its 65,300 participants enrollment target places it among the larger protocols in the corpus, above the 1,402-participant average among 58,714 other NA trials with a reported enrollment target (4558% higher).
The record links to 0 conditions, and to 2 interventions - of which Patient Navigation (PN) is the first listed.
NCT04939519 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04939519 about?
NCT04939519 is a clinical study titled "SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Vaccination Rates Among Utah Community Health Centers". SCALE-UP Utah is a community-academic partnership to address COVID-19 among Utah community health centers. The long-term objective of the project is to increase the reach, acceptance, and uptake of COVID-19 vaccines among Utah's Community Health Center patient population. The study will compare two ...
What is the current status of trial NCT04939519?
This trial is currently completed. It is a NA study. The enrollment target is 65,300 participants. The study started on 2021-03-29. Estimated completion is 2023-02-28.
What interventions are being tested in trial NCT04939519?
The interventions under investigation include: Patient Navigation (PN) (BEHAVIORAL), Text-Messaging (TM) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04939519?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04939519's enrollment target sits among peer trials
65,300 4th of 2000 higher than 1,997 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04473833 · 65,000 participants · NA
Transvaginal Ultrasonography as a Screening Method for Ovarian Cancer
- NCT05128006 · 63,200 participants
Direct-to-patient Teledermatology and Computer-assisted Diagnosis
- NCT06003192 · 63,000 participants · NA
Screen Smart: Using Digital Health to Improve HIV Screening and Prevention
- NCT00009633 · 68,000 participants
Follow-up Visit of High Risk Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI